CatalystPit

PCVXVaxcyte, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $56.90 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$8.47B
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-07 · Cowan Elvia (SVP, Finance & CAO) · OTHER
  • 2026-10-07 · Cowan Elvia (SVP, Finance & CAO) · SELL
  • 2026-10-07 · Wassil Jim (EVP, Chief Scientific Ofc, COO) · OTHER
  • 2026-10-07 · Wassil Jim (EVP, Chief Scientific Ofc, COO) · SELL
  • 2026-10-02 · Wassil Jim (EVP, Chief Scientific Ofc, COO) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders361
Shares held206,895,149
Value$11.17B
Percent of shares outstanding139.04%
As of quarter end2026-06-30
RECENT CONGRESSIONAL TRADES
  • 2026-07-16 · Gilbert Cisneros · BUY · $1,001 - $15,000
  • 2026-05-13 · Gilbert Cisneros · BUY · $1,001 - $15,000
  • 2026-05-12 · Gilbert Cisneros · BUY · $1,001 - $15,000
RECENT NEWS
  • Vaxcyte EVP, COO Jim Wassil sells $1.56m in shares
  • Vaxcyte SVP Elvia Cowan sells $1.6 million in company stock
  • Vaxcyte closes $1.15 billion stock and convertible note offerings
  • Vaxcyte prices $500M convertible notes offering
  • Vaxcyte: 'Strong Buy' On VAX-31 Trial Win IPD VAX-31 And Additional Readouts 1st Half 2027
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS